全福生物科技股份有限公司 Approved
最後更新時間 2025/05/02 , 01:49 AM
最後更新時間 2025/05/02 , 01:49 AM
負責人
Lin,Qun
統一編號
54346233
成立日期
2013/07/31
資本額
NT$2,000,000,000
實收資本額
NT$1,323,100,000
股票代號
6885
電話
02-26598586#101
地址
8F, No. 1, Aly. 30, Ln. 358, Rueiguang Rd., Neihu Dist., Taipei City, 114, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Lin,Qun Chairman 0.70%
Jian,Hai-Shan Vice Chairman 0.97%
Ceng,Hui-Jin Director 0.07%
An Fu,Da-Jian-Kang-Yi-Hao-You-Xian-He-Huo Director 9.07%
ISAIAH CAPITAL CO., LTD. Director 0.17%
ZHONG JIA CONSULTANT CO., LTD. Director 0.00%
Li,Zhong-Xi Independent Director 0.00%
Guo,Zong-Ming Independent Director 0.00%
Cheng,Shou-Zhen Independent Director 0.00%
營業項目
  • Other Professional, Scientific and Technical Activities Not Elsewhere Classified(760999)
  • Research and Experimental Development on Natural Sciences and Engineering(721000)
  • Wholesale of Pharmaceutical and Medical Goods(457112)
  • 公司歷程
  • Change Person in Charge to Lin,Qun
    2023/03/13
  • Change Capital to 2,000,000,000
    2020/03/17
  • Change Company Name to BRIM BIOTECHNOLOGY, INC.
    2019/05/07
  • Change Company Name to NO. 7-3, LANE 171, HUIMIN ROAD
    2019/01/03
  • Change Capital to 600,000,000
    2015/10/14
  • Change Capital to 300,000,000
    2014/02/24
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 333 90 526
    Operating cost 311 0 0
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 22 90 526
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 22 90 526
    Operating expenses 344,807 694,215 218,852
    Other gain (loss), net - - -
    Operating profit (loss) -344,785 -694,125 -218,326
    Non-operating income and expenses 29,315 6,103 -55,951
    Net profit (loss) before tax -315,470 -688,022 -274,277
    Income tax expense (benefits) - - -
    Net profit (loss) of ongoing business for the current period -315,470 -688,022 -274,277
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -315,470 -688,022 -274,277
    Other comprehensive profit (loss), net 7,964 -439 7,377
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -307,506 -688,461 -266,900
    Net profit (loss) attributable to owners of parent company - - -
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company - - -
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) -2 -6 -3
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities - - -
    Net cash inflows (outflows) from investing activities - - -
    Net cash inflow (outflow) from financing activities - - -
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period - - -
    Beginning balance of cash and cash equivalents - - -
    Ending balance of cash and cash equivalents - - -
    項目 2024 2023 2022
    Current asset 1,876,157 1,712,962 848,990
    Non-current asset 534,469 65,709 91,000
    Total asset 2,410,626 1,778,671 939,990
    Current liability 350,837 42,050 22,484
    Non-current liability 3,542 108 2,814
    Total liability 354,379 42,158 25,298
    share capital 1,315,129 1,157,540 932,540
    Equity - secruity token - - -
    capital reserve 1,635,780 1,725,244 749,962
    retained earning -884,686 -1,149,216 -771,194
    Other equity -9,976 2,945 3,384
    Treasury stock - - -
    Total equity attributable to owners of parent company - - -
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 2,056,247 1,736,513 914,692
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 10,000 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 15 15 9
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    存款不足之退票事宜
    時間 金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • BRiM biotechnology設計字
  • 全福生物科技
  • BRiM biotechnology設計字(彩色)
  • 全福生物科技(彩色)
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。